NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand total assets
Total assets on the balance sheet at the end of each period.
NutriBand's total assets was $6.29M at Jul 31, 2026. For fiscal 2026 it was $7.55M, up 1.0% from the year before. Over ten years it grew 172.9% a year on average. The highest annual figure on record is $12.74M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $7.55M | +1.0% |
| FY2025 | Jan 31, 2025 | $7.47M | -0.6% |
| FY2024 | Jan 31, 2024 | $7.52M | -20.5% |
| FY2023 | Jan 31, 2023 | $9.46M | -25.8% |
| FY2022 | Jan 31, 2022 | $12.74M | +28.3% |
| FY2021 | Jan 31, 2021 | $9.93M | +351.7% |
| FY2020 | Jan 31, 2020 | $2.20M | -21.7% |
| FY2019 | Jan 31, 2019 | $2.81M | +1602.6% |
| FY2018 | Jan 31, 2018 | $164.90K | +337.1% |
| FY2017 | Jan 31, 2017 | $37.73K | +11332.4% |
| FY2016 | Jan 31, 2016 | $330 | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $6.29M | -38.2% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $6.89M | +12.0% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $7.55M | +1.0% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $8.42M | -32.9% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $10.18M | -25.4% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $6.15M | -59.4% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $7.47M | -0.6% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $12.54M | +47.2% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $13.63M | +38.1% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $15.15M | +74.7% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $7.52M | -20.5% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $8.52M | -20.1% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $9.87M | -13.3% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $8.68M | -27.6% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $9.46M | -25.8% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $10.67M | -30.8% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $11.39M | +7.8% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $11.98M | +20.7% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $12.74M | +26.4% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $15.43M | +601.5% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $10.56M | +380.3% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $9.93M | +351.7% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $10.08M | +313.0% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $2.20M | -6.5% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $2.20M | -12.7% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $2.20M | -21.7% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $2.44M | -6.9% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $2.35M | -23.4% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $2.52M | +2171.8% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $2.81M | +1602.6% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $2.62M | +8.4% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $3.07M | +22.4% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $110.89K | +1047.5% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $164.90K | +337.1% |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $2.42M | +14035.6% |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $2.51M | +7180.8% |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $9.66K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | $37.73K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | $17.10K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | $34.45K | – |
See a number that looks wrong?